Showing results (31-40 of 251) with videos related to
Sort By:
Pageof 26
Neuromuscular Disorders : NMD|January 14, 2017
Resistant myasthenia gravis and rituximab: A monocentric retrospective study of 28 patientsVadim Afanasiev, Sophie Demeret, Francis Bolgert, et al.Neurology. Clinical Practice|May 13, 2024
Innovative Therapeutic Approaches in Congenital Myasthenic SyndromesMohamed I Kediha, Meriem Tazir, Damien Sternberg, et al.Medecine Sciences : M/S|November 17, 2023
[Congenital myasthenic syndromes with kinetic abnormalities of the acetylcholine receptor]Mohamed Islam Kediha, Meriem Tazir, Damien Sternberg, et al.Journal of Neuromuscular Diseases|November 19, 2016
Orthopedic Management of Scoliosis by Garches Brace and Spinal Fusion in SMA Type 2 ChildrenMichela Catteruccia, Carole Vuillerot, Isabelle Vaugier, et al.Human Molecular Genetics|August 23, 2008
A mouse model for congenital myasthenic syndrome due to MuSK mutations reveals defects in structure and function of neuromuscular junctionsFrédéric Chevessier, Emmanuelle Girard, Jordi Molgó, et al.Human Molecular Genetics|October 22, 2004
MUSK, a new target for mutations causing congenital myasthenic syndromeFrédéric Chevessier, Brice Faraut, Aymeric Ravel-Chapuis, et al.Journal De La Societe De Biologie|August 24, 2005
[Pathophysiological characterization of congenital myasthenic syndromes: the example of mutations in the MUSK gene]Frédéric Chevessier, Brice Faraut, Aymeric Ravel-Chapuis, et al.Plos One|January 18, 2013
A mutation causes MuSK reduced sensitivity to agrin and congenital myastheniaAsma Ben Ammar, Payam Soltanzadeh, Stéphanie Bauché, et al.BMC Neurology|September 20, 2018
Marathons and myasthenia gravis: a case reportSimone Birnbaum, Tarek Sharshar, Bruno Eymard, et al.Stem Cell Research|December 29, 2020
Generation of a human induced pluripotent stem cell line (iPSC) from peripheral blood mononuclear cells of a patient with a myasthenic syndrome due to mutation in COLQSusie Barbeau, Romain Desprat, Bruno Eymard, et al.Pageof 26